Thelansis

 Graves ophthalmopathy (also known as Graves’ eye disease, Graves’ ophthalmopathy, Graves’ orbitopathy, TED) is an autoimmune inflammatory process that affects the periorbital and orbital tissue, closely associated with dysthyroidism. Thyroid eye disease is an autoimmune disorder. Usually caused by Graves’ disease, but it can also be associated with Hashimoto's thyroiditis. ·        It is estimated to be 16 per 100,000 women in the general population and 2.9 per 100,000 men in the general population   Thelansis’s “Graves Ophthalmopathy Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2023 To 2033" covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Graves Ophthalmopathy treatment modalities options for eight major markets (...

 Graves ophthalmopathy (also known as Graves’ eye disease, Graves’ ophthalmopathy, Graves’ orbitopathy, TED) is an autoimmune inflammatory process that affects the periorbital and orbital tissue, closely associated with dysthyroidism. Thyroid eye disease is an autoimmune disorder. Usually caused by Graves’ disease, but it can also be associated with Hashimoto's thyroiditis. ·        It is estimated to be 16 per 100,000 women in the general population and 2.9 per 100,000 men in the general population. Thelansis’s “Graves Ophthalmopathy Market Outlook, Epidemiology, Competitive Landscape , and Market Forecast Report – 2021 To 2032" covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Graves Ophthalmopathy treatment modalities options for eight major markets (USA, Ge...

  Graves ophthalmopathy (also known as Graves’ eye disease, Graves’ ophthalmopathy, Graves’ orbitopathy, TED) is an autoimmune inflammatory process that affects the orbital and periorbital tissue, closely associated with dysthyroidism.   Etiology- Thyroid eye disease is an autoimmune disorder. Usually caused by Graves’ disease, but it can also be associated with Hashimoto's thyroiditis.   Epidemiology- It is estimated to be 16 per 100,000 women in the general population, and 2.9 per 100,000 men in the general population.   The competitive landscape of Graves Ophthalmopathy includes country-specific approved as well as pipeline therapies. Any asset/product-specific designation or review and Accelerated Approval are being tracked and supplemented with analyst commentary. KOLs insights of Graves Ophthalmopathy across 8 MM market from the centre of Excellence/ Public/ Private hospitals participated in the study. Insights around current treatment landsc...